InvestorsObserver
×
News Home

Should You Buy AstraZeneca plc (AZN) in Drug Manufacturers - General Industry?

Wednesday, May 25, 2022 06:31 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy AstraZeneca plc (AZN) in Drug Manufacturers - General Industry?

AstraZeneca plc (AZN) leads the Drug Manufacturers - General industry with an overall score of 78. AZN is up 17.11% so far this year after the company closed yesterday at $66.65. The overall score measures the company's performance based-off both short and long term indicators and means that AZN scores better than 78% of the overall market.

Overall Score - 78
AZN has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on AZN!
AstraZeneca plc is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 57. This means that, on average, the stocks in this industry score higher than 57% of the stock market.
To see InvestorsObserver's Sentiment Score for AstraZeneca plc click here. AZN has been trading bullishly recently. The stock is trading up 1.54% this week following yesterday's decline. AZN has an average analyst ranking of Strong Buy with an average price target of $74.25. Click Here to get the full Stock Report for AstraZeneca plc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App